Cargando…

Central versus Peripheral CTEPH—Clinical and Hemodynamic Specifications

Background and Objectives: Chronic thromboembolic pulmonary hypertension (CTEPH) is a chronic progressive disease, resulting from persistent arterial obstruction combined with small-vessel remodeling. Central and peripheral CTEPH are distinguished, according to the dominant lesion’s location. This i...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaldararova, Monika, Simkova, Iveta, Bohacekova, Marcela, Reptova, Adriana, Hlavata, Tereza, Pacak, Jozef, Lindner, Jaroslav, Jansa, Pavel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9696046/
https://www.ncbi.nlm.nih.gov/pubmed/36363494
http://dx.doi.org/10.3390/medicina58111538
_version_ 1784838218929143808
author Kaldararova, Monika
Simkova, Iveta
Bohacekova, Marcela
Reptova, Adriana
Hlavata, Tereza
Pacak, Jozef
Lindner, Jaroslav
Jansa, Pavel
author_facet Kaldararova, Monika
Simkova, Iveta
Bohacekova, Marcela
Reptova, Adriana
Hlavata, Tereza
Pacak, Jozef
Lindner, Jaroslav
Jansa, Pavel
author_sort Kaldararova, Monika
collection PubMed
description Background and Objectives: Chronic thromboembolic pulmonary hypertension (CTEPH) is a chronic progressive disease, resulting from persistent arterial obstruction combined with small-vessel remodeling. Central and peripheral CTEPH are distinguished, according to the dominant lesion’s location. This is important for surgical or percutaneous interventional assessment or for medical treatment. Material and Methods: Eighty-one patients (51 male/30 female) with confirmed CTEPH were analyzed, while the CENTRAL type included 51 patients (63%) and the PERIPHERAL type 30 patients (37%). Results: A significant difference in CENTRAL type vs. PERIPHERAL type was determined in gender (male 72.5% vs. 46.7%; p = 0.0198). No difference was found in age, functional status, or echocardiographic parameters. Invasive hemodynamic parameters showed a significant difference in mean pulmonary arterial pressure (46 vs. 58 mmHg; p = 0.0002), transpulmonary gradient (34 vs. 47 mmHg; p = 0.0005), and cardiac index (2.04 vs. 2.5 L.min.m(2); p = 0.02) but not in pulmonary vascular resistance. Risk factors showed a significant difference only in acute pulmonary embolism (93.8% vs. 60%; p = 0.0002) and malignancy (2% vs. 13.3%; p = 0.0426). Conclusions: Our study showed hemodynamic differences between CENTRAL type vs. PERIPHERAL type CTEPH with a worse hemodynamic picture in CENTRAL form. This may indicate a different pathophysiological response and/or possible additional influences contributing especially to the peripheral pulmonary bed affection.
format Online
Article
Text
id pubmed-9696046
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-96960462022-11-26 Central versus Peripheral CTEPH—Clinical and Hemodynamic Specifications Kaldararova, Monika Simkova, Iveta Bohacekova, Marcela Reptova, Adriana Hlavata, Tereza Pacak, Jozef Lindner, Jaroslav Jansa, Pavel Medicina (Kaunas) Article Background and Objectives: Chronic thromboembolic pulmonary hypertension (CTEPH) is a chronic progressive disease, resulting from persistent arterial obstruction combined with small-vessel remodeling. Central and peripheral CTEPH are distinguished, according to the dominant lesion’s location. This is important for surgical or percutaneous interventional assessment or for medical treatment. Material and Methods: Eighty-one patients (51 male/30 female) with confirmed CTEPH were analyzed, while the CENTRAL type included 51 patients (63%) and the PERIPHERAL type 30 patients (37%). Results: A significant difference in CENTRAL type vs. PERIPHERAL type was determined in gender (male 72.5% vs. 46.7%; p = 0.0198). No difference was found in age, functional status, or echocardiographic parameters. Invasive hemodynamic parameters showed a significant difference in mean pulmonary arterial pressure (46 vs. 58 mmHg; p = 0.0002), transpulmonary gradient (34 vs. 47 mmHg; p = 0.0005), and cardiac index (2.04 vs. 2.5 L.min.m(2); p = 0.02) but not in pulmonary vascular resistance. Risk factors showed a significant difference only in acute pulmonary embolism (93.8% vs. 60%; p = 0.0002) and malignancy (2% vs. 13.3%; p = 0.0426). Conclusions: Our study showed hemodynamic differences between CENTRAL type vs. PERIPHERAL type CTEPH with a worse hemodynamic picture in CENTRAL form. This may indicate a different pathophysiological response and/or possible additional influences contributing especially to the peripheral pulmonary bed affection. MDPI 2022-10-27 /pmc/articles/PMC9696046/ /pubmed/36363494 http://dx.doi.org/10.3390/medicina58111538 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Kaldararova, Monika
Simkova, Iveta
Bohacekova, Marcela
Reptova, Adriana
Hlavata, Tereza
Pacak, Jozef
Lindner, Jaroslav
Jansa, Pavel
Central versus Peripheral CTEPH—Clinical and Hemodynamic Specifications
title Central versus Peripheral CTEPH—Clinical and Hemodynamic Specifications
title_full Central versus Peripheral CTEPH—Clinical and Hemodynamic Specifications
title_fullStr Central versus Peripheral CTEPH—Clinical and Hemodynamic Specifications
title_full_unstemmed Central versus Peripheral CTEPH—Clinical and Hemodynamic Specifications
title_short Central versus Peripheral CTEPH—Clinical and Hemodynamic Specifications
title_sort central versus peripheral cteph—clinical and hemodynamic specifications
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9696046/
https://www.ncbi.nlm.nih.gov/pubmed/36363494
http://dx.doi.org/10.3390/medicina58111538
work_keys_str_mv AT kaldararovamonika centralversusperipheralctephclinicalandhemodynamicspecifications
AT simkovaiveta centralversusperipheralctephclinicalandhemodynamicspecifications
AT bohacekovamarcela centralversusperipheralctephclinicalandhemodynamicspecifications
AT reptovaadriana centralversusperipheralctephclinicalandhemodynamicspecifications
AT hlavatatereza centralversusperipheralctephclinicalandhemodynamicspecifications
AT pacakjozef centralversusperipheralctephclinicalandhemodynamicspecifications
AT lindnerjaroslav centralversusperipheralctephclinicalandhemodynamicspecifications
AT jansapavel centralversusperipheralctephclinicalandhemodynamicspecifications